Tenaya Therapeutics: A High-Risk Bet on Cutting-Edge Cardiac Gene Therapy
Overview
Tenaya Therapeutics focuses on developing therapies for serious heart diseases using a diversified pipeline including gene therapies, small-molecule drugs, and cellular reprogramming. Despite having no approved products yet, its leading programs have entered clinical trials, positioning the company at the forefront of cardiovascular medicine. With a mission to deliver curative treatments for both rare and widespread cardiac conditions, Tenaya targets significant unmet medical needs with innovative strategies.